SCHEMBL1825846

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

	Compound	similarity	top predicted	shared targets
	SCHEMBL19532043	0.86	PDPK1 (0.44)	PDPK1ABL1NOS3NOS1NOS2
	SCHEMBL32675655	0.86	PDPK1 (0.44)	PDPK1ABL1NOS3NOS1NOS2
	SCHEMBL21634972	0.86	PDPK1 (0.44)	PDPK1ABL1NOS3NOS1NOS2
	SCHEMBL4765233	0.82	PDPK1 (0.64)	PDPK1ABL1NOS3NOS1NOS2
	SCHEMBL30449138	0.77	—	—
	SCHEMBL14810008	0.77	—	—
	SCHEMBL557986	0.76	NOS3 (0.62)	PDPK1ABL1NOS3NOS1NOS2
	SCHEMBL557742	0.76	PDPK1 (0.52)	PDPK1ABL1NOS3NOS1NOS2
	SCHEMBL22833705	0.76	PDPK1 (0.57)	PDPK1ABL1NOS3NOS1NOS2
	SCHEMBL559391	0.76	ABL1 (0.64)	PDPK1ABL1NOS3NOS1NOS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.